| A review on covid-19: From molecular variability, drug development to status of vaccine clinical trials | International Journal of Pharma and Bio Sciences | 2022 |
| Compassionate Use of Tocilizumab in Severe SARS-CoV2 Pneumonia. When late administration is too late | | |
| Diarrhea when COVID-19 in adults | Eksperimental'naya I Klinicheskaya Gastroenterologiya | 2020 |
| COVID-19: the new challenge for rheumatologists | Sovremennaya Revmatologiya | 2020 |
| A Minireview of the Promising Drugs and Vaccines in Pipeline for the Treatment of COVID-19 and Current Update on Clinical Trials | Frontiers in Molecular Biosciences | 2021 |
| Mechanistic insight into anti-COVID-19 drugs: recent trends and advancements | 3 Biotech | 2021 |
| Understanding COVID-19 Pandemic: Molecular Mechanisms and Potential Therapeutic Strategies. An Evidence-Based Review | Journal of Inflammation Research | 2021 |
| Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19 | Journal of Clinical Immunology | 2021 |
| Compassionate use of tocilizumab in severe SARS-CoV2 pneumonia | International Journal of Infectious Diseases | 2021 |
| Repurposed Tocilizumab in Patients with Severe COVID-19 | Journal of Immunology | 2021 |
| Repurposing drugs for the management of COVID-19 | Expert Opinion on Therapeutic Patents | 2021 |
| An overview of antiviral strategies for coronavirus 2 (SARS-CoV-2) infection with special reference to antimalarial drugs chloroquine and hydroxychloroquine | International Journal of Clinical Practice | 2021 |
| Systemic immunosuppressive therapy for inflammatory skin diseases in children: Expert consensus-based guidance for clinical decision-making during the COVID-19 pandemic | Pediatric Dermatology | 2020 |
| Elevated interleukin-6 and severe COVID-19: A meta-analysis | Journal of Medical Virology | 2020 |
| Current pharmacological treatments for COVID-19: What's next? | British Journal of Pharmacology | 2020 |
| Translating IL-6 biology into effective treatments | Nature Reviews Rheumatology | 2020 |
| A Comprehensive Review of Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome | Journal of Clinical Pharmacology | 2020 |
| IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy? | Pharmaceutical Medicine | 2020 |
| The COVID-19 Pandemic and its Impact on the Cardio-Oncology Population | Current Oncology Reports | 2020 |
| Drug repurposing against COVID-19: focus on anticancer agents | Journal of Experimental and Clinical Cancer Research | 2020 |
| Going Viral: Management of IBD in the Era of the COVID-19 Pandemic | Digestive Diseases and Sciences | 2020 |
| Pandemic Perspective: Commonalities Between COVID-19 and Cardio-Oncology | Frontiers in Cardiovascular Medicine | 2020 |
| Pharmacological treatments of COVID-19 | Pharmacological Reports | 2020 |
| The Dual Role of Echocardiography in the Diagnosis of Acute Cardiac Complications and Treatment Monitoring for Coronavirus Disease 2019 (COVID-19) | Frontiers in Cardiovascular Medicine | 2020 |
| Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era | Therapeutics and Clinical Risk Management | 2020 |
| Severe prolonged neutropenia following administration of tocilizumab in a patient affected by COVID-19: a case report and brief review of the literature | Drugs and Therapy Perspectives | 2020 |
| Toll-like receptors and COVID-19: a two-faced story with an exciting ending | Future Science OA | 2020 |
| Why Do Immunosuppressed Patients with Inflammatory Bowel Disease Not Seem to Be at a Higher Risk of COVID-19? | Digestive Diseases and Sciences | 2021 |
